mcdougal

44
Systemic Toxicity from Skin Exposures (or what may happen with a failure to decontaminate) James N. McDougal, Ph.D. Pharmacology and Toxicology Boonshoft School of Medicine Wright State University Dayton OH

Upload: div-chas

Post on 26-May-2015

358 views

Category:

Business


0 download

TRANSCRIPT

Systemic Toxicity from Skin Exposures

(or what may happen with a failure to decontaminate)

James N. McDougal, Ph.D.Pharmacology and ToxicologyBoonshoft School of MedicineWright State UniversityDayton OH

ACS Advances in Decontamination 2006

Purpose

Summarize and evaluate information available on

systemic toxicity of specific chemicals and chemical

categories

ACS Advances in Decontamination 2006

Overview

• Characteristics of cutaneous exposures• How systemic toxicity is assessed• Case reports of chemicals causing

lethality• Chemicals recognized to cause illness

ACS Advances in Decontamination 2006

ExternalDose

(skin surface)

SurfaceContamination

Transfer

LiquidSplash

Vaporor

Aerosol

Exposure Scenarios

ACS Advances in Decontamination 2006

Cutaneous Toxicity

Two independent factors are responsible:

• Penetration through the skin• Toxic potency

ACS Advances in Decontamination 2006

Penetration Through Skin

ExternalExposure

InternalDoseKp

Flux

ACS Advances in Decontamination 2006

Toxic Potency

• Mechanism dependent:• Receptors• DNA• Enzymes • Membranes

• Lethal Dose (LD50)• Lowest observable effect level (LOEL)• No observable effect level (NOEL)

ACS Advances in Decontamination 2006

How do we Evaluate Cutaneous Toxicity?

• Human experience• Studies in animals (dermal LD50, etc.)• ACGIH skin notation • Calculations:

• Based on permeability• Route-to-route extrapolations• Structure-activity

ACS Advances in Decontamination 2006

Human Experience

• Epidemiology studies• “Realistic” exposures• Exposure parameters usually very uncertain• Require large numbers of individuals

• Case Reports• Often accidents or unusual occurrences

ACS Advances in Decontamination 2006

Chemical Mixtures

• Very few dermal exposures to “pure” chemicals in the workplace

ACS Advances in Decontamination 2006

Mixed Exposures

• Function of lung– maximize absorption• Function of skin – minimize absorption• Most dermal exposures have inhalation

component• Vapor• Dust or aerosol

• Whole body vapor exposure – less than 10% of the body burden from skin

ACS Advances in Decontamination 2006

Skin Notation

• American Congress of Governmental Industrial Hygienists (ACGIH)

• “potential significant contribution to overall exposures by cutaneous route.”

• 24% of the chemicals with threshold limit values (TLVs) also have a skin notation

ACS Advances in Decontamination 2006

Animal Studies

• Dermal toxicity studies (i.e. LD50)• High exposure levels• Hard to control exposure• May not extrapolate to humans very well

• Skin penetration studies• In vitro with human or animal skin• Variable results depending on methods

ACS Advances in Decontamination 2006

Route-to-route Extrapolations

• Oral or inhalation toxicity• Requires known permeability• Assumes no route of entry effects

ACS Advances in Decontamination 2006

Structure-Activity

Correlation approach (Potts-Guy)• Predicts permeability (Kp) based on

octanol/water partition coefficient and molecular weight

• Only for penetration from aqueous solution• Frequently differs from experimental

measurements by an order of magnitude

Specific ChemicalsCausingMortality

ACS Advances in Decontamination 2006

Pesticides

ACS Advances in Decontamination 2006

Pesticides

• Widely used, hundreds of compounds designed to be toxic to insects

• Worldwide• 3 million cases of poisoning/yr• About 220,000 deaths worldwide (1990)

• Developing countries• 13-fold incidence of poisoning• 85% of pesticide use

ACS Advances in Decontamination 2006

Pesticides

California Pesticide Illness Surveillance Program (PISP) summarizes illness/injury in 2000 by type of exposure

• Direct contact with pesticides 40%• Spray, mist or fumes 40%• Residue 20%

ACS Advances in Decontamination 2006

Acids

• Hydrofluoric acid• OSHA investigated 4 (skin alone) and 11

mixed exposure deaths in 11 years• >2.5% BSA may be lethal (hypocalcemia)• Inhalation can contribute

• Monochloroacetic acid• ECETOC reports at least 26 fatalities (18yrs)• >10% BSA may be lethal (lactic acidosis)

ACS Advances in Decontamination 2006

Salicylic acid

• Treatment for psoriasis and other skin problems as a 3 or 6% ointment

• 13 deaths recorded• Also causes nausea, confusion and

hallucinations

ACS Advances in Decontamination 2006

Dichlorophenol

• Feedstock chemical• 5 deaths in chemical industry (18 yr)• Mechanism – uncouples oxidative

phosphorylation• Inhalation a component

ACS Advances in Decontamination 2006

Dimethyl Mercury

• Use rare – only 100 labs worldwide as a NMR standard

• Lethality rare – only 4 known cases• Penetrates latex and PVC gloves • Binds to S-containing amino acids

and kills nerve cells

ACS Advances in Decontamination 2006

Dimethyl Mercury

• Aug 96 - Dartmouth Chemistry Professor spilled “several drops” on glove

• Jan 97 – tingly, slurred speech & balance problems

• 3 weeks later lapsed into coma and died in Jun 97

Dr. Karen Wetterhahn

ACS Advances in Decontamination 2006

Chemical Warfare Agents

• Nerve agents• Sarin• Tabun• Soman• VX

• All lethal through the skin

ACS Advances in Decontamination 2006

Cancer-causing Chemicals

• Very few documented cases of systemic cancer from skin exposures• Benzidine – bladder tumors• Arsenic – hemangiosarcoma of liver

• Many chemicals cause systemic cancers and are absorbed through the skin

• We don’t know if enough can penetrate the skin to cause cancer

ACS Advances in Decontamination 2006

Phenol

• Was used as antiseptic• May cause death by

protein denaturation• 64 sq in. (2% BSA)

exposure was lethal• Volatile enough to have

inhalation component

ACS Advances in Decontamination 2006

Hexachlorophene

• Hexachlorophene (6.3%) added to “baby powder” in France due to manufacturing error

• Caused encephalopathy and ulcerative skin lesions

• 36 of 204 exposed children died

ACS Advances in Decontamination 2006

Hexachlorophene

• pHisoHex soap contains 3% hexachlorophene

• 248 children autopsied at U of Washington

• Encephalopathy in 17 neonates related to undiluted bathing in pHisoHex

ChemicalsCausing

Morbidity

ACS Advances in Decontamination 2006

Petroleum & Petroleum Products

• CNS depression• Kidney and other cancers• Liver lesions• Skin irritation

ACS Advances in Decontamination 2006

Solvents

• CNS depression• Liver and kidney cancers• Leukemia• DNA damage• Cardiac arrhythmias

ACS Advances in Decontamination 2006

Inorganic Chemicals

• Variety of cancers• CNS effects• Cholinesterase inhibition• Metabolic effects

ACS Advances in Decontamination 2006

Systemic Morbidity

• Selenium sulfide • Nitroglycerin• Glycol ether• Inorganic mercury• Alkyl lead• Boric acid

• DEET• Alcohols• Benzocaine• Lindane• Other topical drugs• TCDD

ACS Advances in Decontamination 2006

Green Tobacco Sickness

• Caused by working in wet tobacco fields• Migrant workers

exposed 8-12 weeks per year

• Break off flowers at top of 4-6 ft high plants

• Harvest leaves by hand picking from bottom

ACS Advances in Decontamination 2006

Green Tobacco Sickness

• Headache, nausea and dizziness• Illness reported in 9% of

workers• Hospital treatment in 1%

of workers• Nicotine poisoning from

dermal contact• Smoking may be

protective• Tolerance may occur

ACS Advances in Decontamination 2006

Summary

• The skin DOES provide good protection from absorption compared to other routes

• There are chemicals that can and do cause systemic toxicity (lethality and morbidity) from skin exposures

• We do not know if the vast majority of toxic chemicals cause toxicity from skin exposures

ACS Advances in Decontamination 2006

ACS Advances in Decontamination 2006

ACS Advances in Decontamination 2006

ACS Advances in Decontamination 2006

ACS Advances in Decontamination 2006